SK bioscience Advances RSV Prevention with Novel Monoclonal Antibody Through Gates MRI License SK bioscience is set to develop a new monoclonal antibody for RSV prevention, showcasing a commitment to equitable global health through a recent partnership with Gates MRI.

SK bioscience Advances RSV Prevention with Novel Monoclonal Antibody Through Gates MRI License #South_Korea #RSV #Incheon #SK_bioscience #Gates_Medical_Research